Poseida Therapeutics (PSTX)

Poseida Therapeutics (PSTX) Financial Statements


Poseida Therapeutics Financial Overview

Poseida Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.236; its P/E ratio is -10.08; Poseida Therapeutics is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $-0.29. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 20.01M$ 10.34M$ 10.05M$ 116.31M$ 2.70M
Gross Profit$ 20.01M$ 10.34M$ 10.05M--
EBIT$ -25.32M$ -36.82M$ -31.05M$ 72.44M$ -41.49M
EBITDA$ -25.83M$ -38.12M$ -33.75M$ 73.79M$ -40.23M
Net Income Common Stockholders$ -27.46M$ -38.85M$ -33.32M$ 70.41M$ -43.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 214.61M$ 247.20M$ 282.49M$ 278.99M$ 142.56M
Total Assets$ 281.21M$ 313.62M$ 351.84M$ 380.48M$ 205.46M
Total Debt$ 87.08M$ 87.89M$ 88.75M$ 90.63M$ 91.55M
Net Debt$ -127.53M$ -159.31M$ -193.74M$ -188.35M$ -51.00M
Total Liabilities$ 145.91M$ 156.06M$ 164.24M$ 164.17M$ 139.66M
Stockholders Equity$ 135.26M$ 157.56M$ 187.59M$ 216.31M$ 65.80M
Cash Flow-
Free Cash Flow$ -34.50M$ -38.81M$ 2.14M$ 60.17M$ -40.95M
Operating Cash Flow$ -33.32M$ -38.03M$ 2.40M$ 61.88M$ -39.73M
Investing Cash Flow$ 43.07M$ -4.42M$ -85.89M$ -35.87M$ -80.83M
Financing Cash Flow-$ 1.19M$ 58.00K$ 75.84M$ 32.00K
Currency in USD

Poseida Therapeutics Earnings and Revenue History

Poseida Therapeutics Debt to Assets

Poseida Therapeutics Cash Flow

Poseida Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis